Pharmaceutical industry is an important part of China's national economy, as an important part of the Shanghai and Shenzhen markets, pharmaceutical stocks are highly sought after by institutional investors, is a typical defensive plate. So what are the pharmaceutical concept stocks?
002653 Hesco: The company is mainly engaged in the research and development, production and sales of chemical pharmaceutical preparations and APIs, the company to the new product innovation of prescription drugs imitation as the core, adhere to the market-oriented technology research and development. The company has built up a national agent sales system for its leading products in the form of regional agent sales model, and is a leading player in the field of parenteral nutritional drugs, specialty anti-infective drugs, and drugs for liver and gallbladder diseases in the country
002030 Daan Genetics: The company is a high-tech biomedical enterprise that integrates research, development, pilot testing, production and application, with molecular biology technology as the leading one. In molecular biology technology, especially gene diagnostic technology and its reagent products are always in the lead in the research, development and application. It is the leading enterprise in the field of fluorescence quantitative PCR diagnostic technology in China, with a market share of more than 70%
300181 Zoli Pharmaceuticals: the company is a modern biotechnology enterprise utilizing fermentation technology to engage in the development, production and sales of downstream traditional Chinese medicinal products of Wuling ginseng, with the main product being Wuling capsule, which is a class 1 new drug of the country, and is an exclusive variety listed in the national medical insurance, with the function of nourishing the heart and tranquillizing the mind and tonifying the kidneys and brain. It is mainly used for the treatment of neurasthenia, anxiety, depression and insomnia.
600587 Xinhua Medical: the company is China's largest sterilization equipment development and production base, through the Ministry of Science and Technology and the Chinese Academy of Sciences, respectively, the organization of high-tech enterprises double-high certification
300119 Ruipu Biological: the company is a set of veterinary biological products and veterinary preparations research and development, production, sales and technical services in one of the high-tech enterprises.
600867 Tonghua Dongbao: the company is a production of Chinese, western patent medicine and biological drugs of large-scale pharmaceutical enterprises, the national key high-tech enterprises, has become the world has a considerable scale of human insulin production base one of the world
002589 Ruikang medicine: the company is the Shandong Province as the target market, to the scale of hospitals and the basic medical market for direct sales as the The company is a pharmaceutical commercial enterprise with Shandong Province as its target market, with direct sales to above-scale hospitals and the basic medical market as its main business, supplemented by commercial distribution, with the qualification and capability of modern logistics of pharmaceuticals, and can adopt e-commerce and other modernized means of transaction to operate
300003 Lepu Medical: The company is a leading enterprise in the domestic vacuum blood collection system industry, and is the leader of the domestic variation control technology for the pre-analysis of specimens for the clinical testing laboratories. The company has obvious competitive advantages in the field related to specimen collection, pretreatment and pre-analytical variation control
600332 Baiyunshan: The company, as a large-scale pharmaceutical enterprise integrating manufacturing, distribution and research and development,**** owns eight proprietary Chinese medicines manufacturers, three pharmaceutical trading enterprises and two pharmaceutical research and development enterprises. With Chen Li Ji, Wang Lao Ji, Jing Xiu Tang, Pan Gao Shou and other centuries-old brands, the production of more than 400 varieties of proprietary Chinese medicines, the national protection of 40 varieties of traditional Chinese medicine
300049 Fury: the company is the first to put the theory of anti-hepatic fibrosis industrialization of the company, opened up anti-hepatic fibrosis diagnosis and treatment of the market, with the advantage of guiding the development of anti-hepatic fibrosis market
600833 The first medicine: the company through the reorganization of the successful transformation of the pharmaceutical industry and actively develop the chain of pharmaceutical sales model; has formed to the country and even Asia's largest drugstore - Shanghai first medicine store. In Shanghai's medical system reform, the company's subordinate medicine store, Linglin pharmacy, Boshan pharmacy and other 7 pharmacies have been designated as Shanghai medical insurance designated pharmacy, accounting for one-fifth of the designated pharmacies in Shanghai
600420 Modern Pharmaceuticals: the company is currently the largest domestic production of lipoic acid API, 90% of the products are exported to Japan and Europe. The company is also the only domestic enterprise to master the chiral splitting technology of lipoic acid, which can produce high-end products with low residual lipoic acid
600664 Harbin Pharmaceuticals: the company has a complete industrial chain and strong core competitiveness, forming five series of products, including antibiotics, Chinese medicine powder injection, tonic health care, high-grade proprietary Chinese medicines and bio-engineered medicines, which are obviously leading in the same industry in the country. Advantages
300233Jincheng Medicine: the company is the largest manufacturer of cephalosporin side-chain intermediates, including AE-active ester, ceftazidime side-chain acid active ester, cefixime side-chain acid active ester, furazan ammonium salt, aminothiazoxime acid, triazinyl ring, bis(vinylidene) ketone, and ethyl acetoacetate, etc.
300326Kellettai: the company is mainly engaged in the research and development of vertebral body-forming minimally invasive interventional surgery system, which is the most important product of the company, and has been the first to develop and manufacture such products. The company is mainly engaged in the research and development, production and sales of minimally invasive interventional vertebroplasty systems, which are mainly used in the clinical minimally invasive surgical treatment of vertebral compression fracture due to osteoporosis, including percutaneous vertebroplasty (PVP) surgical system and percutaneous balloon dilatation vertebral kyphoplasty (PKP) surgical system.
002462Jiashitang: The company has already formed a medical business (including pharmaceutical wholesaling and retailing), which is led by pharmaceutical logistics, and is supported by the medical logistics department. The company has formed an operation pattern with pharmaceutical commerce (including pharmaceutical wholesaling and retailing) as the leading business and pharmaceutical logistics as the support, supplemented by pharmaceutical industry, and constructed a complete pharmaceutical commercial system. The company is one of the only 2 community hospital drug distribution enterprises in Beijing
600276 Hengrui Medicine: the company's main business tablets (including antineoplastic drugs), oral solution, suspension, sterile APIs (including antineoplastic drugs), APIs (including antineoplastic drugs), and is a leading antineoplastic drug
300529 Jianfan Bio: it is the leader of the domestic blood perfusion industry. The company has been committed to the research and development, production and sales of blood perfusion products. At present, it has formed a blood purification product system with disposable blood perfusion device, disposable plasma bilirubin adsorbent, DNA immunosorbent column and blood purification equipment as the pillars, occupying more than 80% of the domestic blood perfusion market share, and it is the domestic blood perfusion industry leader and industry leader.
000989 Jiuzitang: the company is a centralized drug production, sales, 6.5 billion acquisition of Youbo Pharmaceuticals, the controlling stake in the change of hands
600557 Kangyuan Pharmaceuticals: is an excellent modernization of traditional Chinese medicine enterprises, in the transformation of the ancient formula of traditional Chinese medicine, the development of new varieties, modernization of the production and the use of modern medical theory to elaborate the mechanism of traditional Chinese medicine, etc., the domestic leading, is the possession of traditional Chinese medicine with the largest number of new medicine certificates, in the research and development of new medicines It is one of the enterprises with the largest number of certificates for new Chinese medicines, the largest number of new medicines under research and development, and the deepest research and development for the modernization and internationalization of Chinese medicines in China
300204 Shutaishin: The company is mainly engaged in the research and development, production and sales of biopharmaceuticals and some chemical medicines, and its main products are the injectable murine nerve growth factor "Sutaisan" and the polyethylene glycol electrolyte dispersant "Shutaishin". The main products are injectable rat nerve growth factor "Sutisan" and polyethylene glycol electrolyte dispersing agent "Shutaiqing", of which "Sutisan" is a national Class I new drug mainly used for neuroprotection and repair of nerve damage, and "Shutaiqing" is a national Class IV new drug mainly used for intestinal cleansing and the treatment of constipation. The company is one of the few manufacturers in China with a wide range of independent vaccine products, including Group A Group C Meningococcal Polysaccharide Conjugate Vaccine, ACYW135 Meningococcal Polysaccharide Vaccine, Microcard (Bifidobacterium bovis for injection) and other independent products, and agency products such as Hib Vaccine and Hepatitis A Live Attenuated Vaccine. >600993 Ma Yinglong: the company is one of the largest manufacturers of hemorrhoidal medicines in China, its predecessor is Ma Yinglong Shengji Pharmacy, which was founded in 1582 during the Wanli period of the Ming Dynasty, and it is an old pharmaceutical enterprise with a history of more than 400 years
000766 Tonghua Golden Horse: the company is a national key production base of traditional Chinese medicines and mainly engages in the development and sale of western and Chinese raw materials and biochemical preparations, with a promising market prospect. The company is mainly engaged in the development and sales of Chinese and Western raw materials, biochemical preparations, market prospects
000566 Hainan Haiyao Pharmaceuticals: the company is the first generic enterprise of the domestic anti-tumor drug Paclitaxel injection and Cefoxitin sodium injection. The main product, Feng Polygonum Gastroenterology Kang Granules, is the company's independent research and development of the national Chinese medicine protection varieties, is currently the exclusive domestic production of varieties, for acute and chronic gastroenteritis, ulcerative colitis and irritable bowel syndrome (IBS) has a good therapeutic effect
600285 Antelope Pharmaceuticals: the company is a large-scale pharmaceutical and biomedical manufacturing enterprises in the central region of China, and has been awarded the "National Top 50 Traditional Chinese Medicine". "National Top 50 Enterprises of Traditional Chinese Medicine", "National Advanced Collective of Traditional Chinese Medicine System", "National Excellent Enterprise of Pharmaceuticals"
002550 Qianhong Pharmaceutical: the company's main The company's main products include heparin sodium (heparin sodium API, heparin preparation), pancreatic kininogenase (enteric-coated tablets, injectable pancreatic kininogenase), and injectable menthyl aminotransferase. 300239 Dongbao Biologicals: The company's technology in genetically recombinant insulin is outstanding, and the increase in the incidence of diabetes has provided a broader market for the product. 600211 Tibet Pharmaceuticals: The company has the world's unique richness of Tibetan medicine: The company has a unique wealth of Tibetan medicine resources in the world, and Tibet's special highland climate gives Tibetan medicine special ingredients, strong potency, natural and environmentally friendly features
002332 Xian Ju Pharmaceutical: The company mainly produces three categories of sex hormone drugs (gynecological and family planning drugs) and anesthesia and muscarinic drugs, with more than 100 varieties, 200 tons of raw materials, 7 billion tablets, and 500 million capsules
002332 Xian Ju Pharmaceutical: The company mainly produces sex hormones (gynecological and family planning drugs) and anesthesia and muscle relaxation drugs, with more than 100 varieties. Capsule
300171 Dongfulong: the company is the largest freeze-drying machine equipment manufacturer, is committed to providing specialized, personalized, customized freeze-drying system solutions for pharmaceutical companies. 2009 the company was the first to launch the freeze-drying system equipment composed of freeze-drying machine, automatic feeding and discharging system and sterile isolation device
002349 Essence Pharmaceuticals: the company is relying on advantageous products to vigorously develop the Chinese pharmaceutical industry, and to develop the Chinese pharmaceutical industry. Relying on advantageous products, the company vigorously explores the market of proprietary Chinese medicine products. Exclusive varieties of Wang's Baochi Pills and Ji Desheng snake tablets for the national Chinese medicine confidential varieties, Wang's Baochi Pills, gold buckwheat tablets and solid cough tablets for the national secondary protection of traditional Chinese medicine varieties
300142 Watson Biological: the company is a national enterprise vaccine R & D technology center and vaccine industrialization base, has undertaken the Ministry of Science and Technology "863" plan and a number of national level. The company has undertaken the "863" program of the Ministry of Science and Technology of China and many other major projects at the national and provincial levels. Focus on the development of the vaccine field, in the development of 13 vaccine products have achieved remarkable results
000028 State Pharmaceutical Consistent: the company is a pharmaceutical industry, pharmaceutical wholesale, retail chain as one of the listed pharmaceutical companies, undertake the Shenzhen Municipal Government's national drug reserve task, and enjoy the right to operate narcotic drugs, and licorice, ephedra franchise
000999 China Resources Sanjiu: the company focuses on the development of brand OTC, Chinese medicine prescription drugs, Chinese medicine granules (decoction-free Chinese medicine), antibiotics, four major pharmaceutical business, brand OTC as the core business, Chinese medicine prescription drugs, Chinese medicine granules for the fast-growing star business
002287 Qizheng Tibetan Medicine: the company focuses on the production, research and development and sales of Tibetan medicine, has developed into a double-leading market of China's Tibetan medicine and topical pain-relieving plasters. Now the company has developed into a double leading enterprise in China's Tibetan medicine industry and external pain-relieving ointment market
600267 Hai Zheng Pharmaceutical: the company is a leading manufacturer of APIs in China, and one of the largest production bases of antibiotics and anti-tumor drugs in China
300294 Burson-Marsteller: the company's main business is engaged in the research and development, production and sale of blood products, which is mainly based on the healthy human plasma as raw material, and the separation and purification technology to combine the effective components of plasma into the blood products. Separation and purification technology to separate the effective components of the preparation of a variety of biologically active preparations, including albumin, immunoglobulin and coagulation factors and other three major categories of products
000591 solar energy: the company is an all-around pharmaceutical enterprise covering the production of pharmaceuticals and pharmaceutical distribution, is the largest pharmaceutical business enterprises in the West, operating more than 10,000 products, with the most complete pharmaceutical business network in the West
600763 Tongce Medical: the company is a medical investment industry, the main business scope for investment management, medical equipment, import and export business, technology development, technology consulting, technology training and technical services
002019 Yifan Medicine: the company is the domestic D-panthenol manufacturers, with the well-known "XINFU" brand, the company's leading products, the company's main product, D-panthenol, is the largest pharmaceutical business enterprise in the west. "brand, the company's leading products vitamin B5, vitamin B5 and other fine chemical industry segments
600201 Biological shares: the company is a biopharmaceutical and real estate development as the leading industry diversified industrial group, is China's veterinary biologics and livestock and poultry vaccine products, one of the leading enterprises
600645 Zhongyuan Xiehe: As the only stem cell industrialization base in China, the company owns only two stem cell bank licenses in the country. Meanwhile, the company owns the largest umbilical cord blood hematopoietic stem cell bank in Asia, and is the first batch of members of the Asian umbilical cord blood bank organization, which is the leading enterprise in the field of domestic bio-genetic research and development
600085 Tongrentang: Tongrentang is the gold standard of Chinese traditional Chinese medicine industry, which was founded in the eighth year of the Kangxi Emperor of the Qing Dynasty (1644-1911), and is one of the leading enterprises of veterinary biologics and livestock and poultry vaccine products in China. Qing Dynasty Kangxi eight years (1669), the controlling shareholder of China Beijing Tongrentang Group by the State Council State-owned Assets Supervision and Administration Commission listed as one of the country's ten major typical enterprises in 2004, is the only one in Beijing, the only one in the pharmaceutical industry, the only one of China's traditional Chinese brands into the national key typical enterprises
300016 Beilu Pharmaceuticals: the company is based on the contrast, psychoneurology, endocrine three major fields. The main business is the production of drugs and drug distribution
600056China Pharmaceuticals: the major shareholder is the China National Technology Import and Export Corporation, in the context of the country's trade surplus continues to grow at a high rate, the company's main business has gained rapid development, high-tech and product import and export business is one of the company's main business, belonging to the business of the profit margins are high
600161 Titan Bio: the company is a leading enterprise in the field of domestic biotechnology, mainly engaged in the research and development, production and sales of vaccines, blood preparations, diagnostic supplies, culture media and other biological products, capable of producing more than 200 products, some of which account for more than 50% of the domestic market share
002118 Zixin Pharmaceuticals: the company is a key high-tech enterprise of the National Torch Program, recognized by the Ministry of Science and Technology of the State, mainly engaged in the research and development of proprietary Chinese medicines, the production and export business. The company is mainly engaged in the research and development, production and sales of proprietary Chinese medicines and planting of Chinese herbal medicines, with the treatment of cardiovascular, cerebrovascular, digestive system diseases and bone injuries as the leading varieties of proprietary Chinese medicines, the existing main products are blood circulation and blood circulation tablets, wake up the brain and rejuvenate the capsule, the compound beneficial liver spirit tablets, musk bone capsule, the four wonderful pills and tonifying the kidneys and tranquilize the spirit of the oral solution and so on
300015 AIER Ophthalmology: The company is one of the largest ophthalmological The company is one of the largest ophthalmology medical institutions in China, and has built 31 professional eye hospitals nationwide. The company mainly carries out myopia treatment, cataract surgery, corneal disease, medical optometry, ocular trauma and other diagnostic and treatment projects, the establishment of myopia surgery special zone, cataract diagnosis and treatment special zone, medical optometry and dispensing glasses center and other professional and technical special zone
000078 Haiwang Biological: the company's main business mainly involves two major areas of pharmaceutical manufacturing and commercial distribution of pharmaceuticals
002433 Tai An Tang: the company's leading products are Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, Chinese medicine, and Chinese medicine. Tong: the company's leading products for the Chinese medicine skin external medicine series, 2010 annual revenue of 218 million yuan, accounting for 69.65%, gross profit margin of 38.41%. For different types of skin diseases, the company took the lead in developing a series of representative Chinese medicine dermatological drug series
000919 Jinling Pharmaceutical: The company belongs to the pharmaceutical industry, for the National Torch Plan key high-tech enterprises, and has formed a Chinese patent medicine as the main, the combination of Chinese and Western medicines for the development of the strategic pattern of the goal. It has been awarded the honorary title of National 520 Key Enterprises and Jiangsu Province Intellectual Property Protection Unit
000518 Sihuan Biologicals: The company has four main products: Delusan (recombinant human interleukin-2 for injection, a new class of anticancer drugs), New Delusan (recombinant human interleukin-2 injection), Xinshengguosheng (recombinant human granulocyte-stimulating factor injection, a new class of drugs), Huanerbo (recombinant human interleukin-2 injection, a new class of drugs). (recombinant human erythropoietin injection, Class II new drug), is one of the enterprises with the most varieties of biopharmaceuticals in China
300255 Changshan Pharmaceuticals: the company's main business is the research and development, production and sales of heparin series products, and it is one of the few leading enterprises with a complete industrial chain of heparin products in China that are capable of engaging in the research and development, production and sales of sodium heparin raw materials and heparin formulations at the same time. One of the leading enterprises in China
300298 Sanno Bio: the company's main business is to utilize the biological sensing technology research and development, production and sales of instant testing products. The main products are micro-blood rapid blood glucose tester and supporting blood glucose test strips, constituting a blood glucose monitoring system, including "SXT-1 type", "stable", "safe and accurate" blood glucose tester, etc., mainly used for blood sugar It is mainly used for blood glucose monitoring
600297Guanghui Automobile: Mainly engaged in the production, wholesale and retail of raw materials, tablets, antibiotics, biochemical drugs, proprietary Chinese medicines, Chinese traditional medicine tablets, etc. It is one of the four giants of penicillin and streptomycin in the country
002422KeLun Pharmaceuticals: The company is one of the pharmaceutical manufacturers with the most complete varieties of infusion solutions and the most comprehensive packaging forms in the infusion solution industry in China
002422KeLun Pharmaceuticals: The company is one of the most complete pharmaceutical manufacturers with the largest variety of infusion solutions in China. One of the manufacturing enterprises